BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32274995)

  • 1. [Study on the optimization of administration regimen of vancomycin in critical patients].
    Shi Y; He J; Mao E; Bian X; Zhou J; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):140-144. PubMed ID: 32274995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
    He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of vancomycin for appropriate dosing in severe infective patients with augmented renal clearance].
    Liu N; Zhang B; Liu Y; Tang J; Dong D; Gu Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):646-651. PubMed ID: 30045791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of vancomycin in patients with severe acute pancreatitis and its influencing factors: analysis of 7 years data].
    He J; Mao E; Jing F; Jiang H; Yang W; Chen E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):491-495. PubMed ID: 28625235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y; Jin L; Liu N; Luo X; Dong D; Tang J; Wang Y; You Y; Liu Y; Chen M; Yu Z; Hao Y; Gu Q
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin AUC
    Brandon HH; Burgess DS; Wallace KL; Autry EB; Olney KB
    Pharmacotherapy; 2024 Apr; 44(4):294-300. PubMed ID: 38533999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients.
    Shen K; Yang M; Fan Y; Liang X; Chen Y; Wu J; Yu J; Zhang H; Wang R; Zhang F; Hang J; Wen X; Li H; Shen L; Zhang Z; Wu S; Shen B; Huang W; Chang C; Shen Y; Ren H; Yuan Q; Song X; Luo X; Zhang H; Yang W; Yang J; Zhang J
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S256-S262. PubMed ID: 30423042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia.
    Suzuki Y; Kawasaki K; Sato Y; Tokimatsu I; Itoh H; Hiramatsu K; Takeyama M; Kadota J
    Chemotherapy; 2012; 58(4):308-12. PubMed ID: 23147106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desired vancomycin trough concentration to achieve an AUC
    Zhang T; Cheng H; Pan Z; Mi J; Dong Y; Zhang Y; Sun D; Du Q; Cheng X; Dong Y
    Basic Clin Pharmacol Toxicol; 2020 Jan; 126(1):75-85. PubMed ID: 31403243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review.
    Rainkie D; Ensom MH; Carr R
    Paediatr Drugs; 2015 Jun; 17(3):245-53. PubMed ID: 25813682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.
    Lanke S; Yu T; Rower JE; Balch AH; Korgenski EK; Sherwin CM
    J Clin Pharmacol; 2017 Jan; 57(1):77-84. PubMed ID: 27291466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
    Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
    Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and pharmacodynamics of antibiotics in septic children treated with extracorporeal membrane oxygenation].
    Zhang HX; Huang JT; Dong J; Gong TZ; Zhang KY; Lu XL; Guo SW
    Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):631-636. PubMed ID: 37385807
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
    Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical verification of vancomycin population pharmacokinetics in patients with augmented renal clearance].
    Lu H; Tang L; Xue S; Zhuang Z; Fang J; Zhao F; Shang E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 May; 30(5):444-448. PubMed ID: 29764549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
    Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
    Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis.
    Chen CY; Xie M; Gong J; Yu N; Wei R; Lei LL; Zhao SM; Li RM; Dong X; Zhang XL; Zhou Y; Li SL; Cui YM
    Front Pharmacol; 2023; 14():1132367. PubMed ID: 37188268
    [No Abstract]   [Full Text] [Related]  

  • 20. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
    Blot S; Koulenti D; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J; Roberts JA
    Crit Care; 2014 May; 18(3):R99. PubMed ID: 24887569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.